◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

10-Q Filing

ZIMMER BIOMET HOLDINGS, INC. CIK: 1136869 Q1 2023
Filing Information
Form Type 10-Q
Accession Number 0000950170-23-016663
Period End Date 20230331
Filing Date 20230502
Fiscal Year 2023
Fiscal Period Q1
XBRL Instance zbh-20230331_htm.xml
Balance Sheet 72 line items
Line Item Tag Value Unit Period
Common stock, par value CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Common stock, par value CommonStockParOrStatedValuePerShare $0.01 USD Point-in-time
Common stock, shares authorized CommonStockSharesAuthorized 1.00B shares Point-in-time
Common stock, shares authorized CommonStockSharesAuthorized 1.00B shares Point-in-time
Common stock, shares issued CommonStockSharesIssued 313.80M shares Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $375.70M USD Point-in-time
Cash and cash equivalents CashAndCashEquivalentsAtCarryingValue $330.20M USD Point-in-time
Common stock, shares issued CommonStockSharesIssued 315.40M shares Point-in-time
Accounts receivable, less allowance for credit losses AccountsReceivableNetCurrent $1.38B USD Point-in-time
Accounts receivable, less allowance for credit losses AccountsReceivableNetCurrent $1.38B USD Point-in-time
Treasury stock, shares TreasuryStockShares 106.90M shares Point-in-time
Treasury stock, shares TreasuryStockShares 104.80M shares Point-in-time
Inventories InventoryNet $2.24B USD Point-in-time
Inventories InventoryNet $2.15B USD Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $522.90M USD Point-in-time
Prepaid expenses and other current assets PrepaidExpenseAndOtherAssetsCurrent $459.50M USD Point-in-time
Total Current Assets AssetsCurrent $4.43B USD Point-in-time
Total Current Assets AssetsCurrent $4.41B USD Point-in-time
Property, plant and equipment, net PropertyPlantAndEquipmentNet $1.87B USD Point-in-time
Property, plant and equipment, net PropertyPlantAndEquipmentNet $1.91B USD Point-in-time
Goodwill Goodwill $8.73B USD Point-in-time
Goodwill Goodwill $8.58B USD Point-in-time
Intangible assets, net IntangibleAssetsNetExcludingGoodwill $5.07B USD Point-in-time
Intangible assets, net IntangibleAssetsNetExcludingGoodwill $5.06B USD Point-in-time
Other assets OtherAssetsNoncurrent $1.12B USD Point-in-time
Other assets OtherAssetsNoncurrent $1.12B USD Point-in-time
Total Assets Assets $21.24B USD Point-in-time
Total Assets Assets $21.07B USD Point-in-time
Accounts payable AccountsPayableCurrent $354.10M USD Point-in-time
Accounts payable AccountsPayableCurrent $397.10M USD Point-in-time
Income taxes payable AccruedIncomeTaxesCurrent $38.50M USD Point-in-time
Income taxes payable AccruedIncomeTaxesCurrent $46.60M USD Point-in-time
Salaries, wages and benefits EmployeeRelatedLiabilitiesCurrent $336.20M USD Point-in-time
Salaries, wages and benefits EmployeeRelatedLiabilitiesCurrent $234.20M USD Point-in-time
Other current liabilities OtherLiabilitiesCurrent $1.09B USD Point-in-time
Other current liabilities OtherLiabilitiesCurrent $1.07B USD Point-in-time
Current portion of long-term debt LongTermDebtCurrent $585.00M USD Point-in-time
Current portion of long-term debt LongTermDebtCurrent $544.30M USD Point-in-time
Total Current Liabilities LiabilitiesCurrent $2.36B USD Point-in-time
Total Current Liabilities LiabilitiesCurrent $2.34B USD Point-in-time
Deferred income taxes, net DeferredIncomeTaxLiabilitiesNet $474.80M USD Point-in-time
Deferred income taxes, net DeferredIncomeTaxLiabilitiesNet $484.60M USD Point-in-time
Long-term income tax payable AccruedIncomeTaxesNoncurrent $423.30M USD Point-in-time
Long-term income tax payable AccruedIncomeTaxesNoncurrent $421.20M USD Point-in-time
Other long-term liabilities OtherLiabilitiesNoncurrent $632.60M USD Point-in-time
Other long-term liabilities OtherLiabilitiesNoncurrent $637.40M USD Point-in-time
Long-term debt LongTermDebtNoncurrent $5.20B USD Point-in-time
Long-term debt LongTermDebtNoncurrent $5.15B USD Point-in-time
Total Liabilities Liabilities $9.04B USD Point-in-time
Total Liabilities Liabilities $9.09B USD Point-in-time
Commitments and Contingencies (Note 16) CommitmentsAndContingencies - USD Point-in-time
Commitments and Contingencies (Note 16) CommitmentsAndContingencies - USD Point-in-time
Common stock, $0.01 par value, one billion shares authorized, 315.4 million shares in 2023 (313.8 million in 2022) issued CommonStockValue $3.20M USD Point-in-time
Common stock, $0.01 par value, one billion shares authorized, 315.4 million shares in 2023 (313.8 million in 2022) issued CommonStockValue $3.10M USD Point-in-time
Paid-in capital AdditionalPaidInCapitalCommonStock $9.50B USD Point-in-time
Paid-in capital AdditionalPaidInCapitalCommonStock $9.69B USD Point-in-time
Retained earnings RetainedEarningsAccumulatedDeficit $9.74B USD Point-in-time
Retained earnings RetainedEarningsAccumulatedDeficit $9.56B USD Point-in-time
Accumulated other comprehensive loss AccumulatedOtherComprehensiveIncomeLossNetOfTax $-178.00M USD Point-in-time
Accumulated other comprehensive loss AccumulatedOtherComprehensiveIncomeLossNetOfTax $-179.30M USD Point-in-time
Treasury stock, 106.9 million shares as of March 31, 2023 (104.8 million as of December 31, 2022) TreasuryStockValue $7.11B USD Point-in-time
Treasury stock, 106.9 million shares as of March 31, 2023 (104.8 million as of December 31, 2022) TreasuryStockValue $6.87B USD Point-in-time
Total Zimmer Biomet Holdings, Inc. stockholders' equity StockholdersEquity $12.15B USD Point-in-time
Total Zimmer Biomet Holdings, Inc. stockholders' equity StockholdersEquity $12.02B USD Point-in-time
Noncontrolling interest MinorityInterest $6.90M USD Point-in-time
Noncontrolling interest MinorityInterest $6.70M USD Point-in-time
Total Stockholders' Equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.16B USD Point-in-time
Total Stockholders' Equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.67B USD Point-in-time
Total Stockholders' Equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.02B USD Point-in-time
Total Stockholders' Equity StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.03B USD Point-in-time
Total Liabilities and Stockholders' Equity LiabilitiesAndStockholdersEquity $21.07B USD Point-in-time
Total Liabilities and Stockholders' Equity LiabilitiesAndStockholdersEquity $21.24B USD Point-in-time
Income Statement 50 line items
Line Item Tag Value Unit Period
Net Sales RevenueFromContractWithCustomerExcludingAssessedTax $1.83B USD 1 Quarter
Net Sales RevenueFromContractWithCustomerExcludingAssessedTax $1.66B USD 1 Quarter
Cost of products sold, excluding intangible asset amortization CostOfGoodsAndServicesSold $500.00M USD 1 Quarter
Cost of products sold, excluding intangible asset amortization CostOfGoodsAndServicesSold $500.80M USD 1 Quarter
Intangible asset amortization AmortizationOfIntangibleAssets $133.40M USD 1 Quarter
Intangible asset amortization AmortizationOfIntangibleAssets $130.80M USD 1 Quarter
Research and development ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost $96.90M USD 1 Quarter
Research and development ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost $110.40M USD 1 Quarter
Selling, general and administrative SellingGeneralAndAdministrativeExpense $684.50M USD 1 Quarter
Selling, general and administrative SellingGeneralAndAdministrativeExpense $715.90M USD 1 Quarter
Restructuring and other cost reduction initiatives RestructuringAndOtherCostReductionInitiatives $43.90M USD 1 Quarter
Restructuring and other cost reduction initiatives RestructuringAndOtherCostReductionInitiatives $41.80M USD 1 Quarter
Quality remediation QualityRemediationCosts $6.50M USD 1 Quarter
Acquisition, integration, divestiture and related AcquisitionIntegrationDivestitureAndRelatedExpenses $1.30M USD 1 Quarter
Acquisition, integration, divestiture and related AcquisitionIntegrationDivestitureAndRelatedExpenses $2.20M USD 1 Quarter
Operating expenses CostsAndExpenses $1.50B USD 1 Quarter
Operating expenses CostsAndExpenses $1.46B USD 1 Quarter
Operating Profit OperatingIncomeLoss $198.40M USD 1 Quarter
Operating Profit OperatingIncomeLoss $327.30M USD 1 Quarter
Other income (expense), net OtherNonoperatingIncomeExpense $7.70M USD 1 Quarter
Other income (expense), net OtherNonoperatingIncomeExpense $-56.10M USD 1 Quarter
Interest expense, net InterestIncomeExpenseNet $-41.10M USD 1 Quarter
Interest expense, net InterestIncomeExpenseNet $-48.20M USD 1 Quarter
Earnings from continuing operations before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $286.80M USD 1 Quarter
Earnings from continuing operations before income taxes IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest $101.20M USD 1 Quarter
Provision for income taxes from continuing operations IncomeTaxExpenseBenefit $54.10M USD 1 Quarter
Provision for income taxes from continuing operations IncomeTaxExpenseBenefit $28.00M USD 1 Quarter
Net Earnings from continuing operations IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest $73.20M USD 1 Quarter
Net Earnings from continuing operations IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest $232.80M USD 1 Quarter
Less: Net earnings attributable to noncontrolling interest IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity $200.00K USD 1 Quarter
Less: Net earnings attributable to noncontrolling interest IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity $200.00K USD 1 Quarter
Net Earnings from Continuing Operations of Zimmer Biomet Holdings, Inc. IncomeLossFromContinuingOperations $73.00M USD 1 Quarter
Net Earnings from Continuing Operations of Zimmer Biomet Holdings, Inc. IncomeLossFromContinuingOperations $232.50M USD 1 Quarter
Loss from discontinued operations, net of taxes IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity $-58.80M USD 1 Quarter
Net Earnings of Zimmer Biomet Holdings, Inc. NetIncomeLoss $232.50M USD 1 Quarter
Net Earnings of Zimmer Biomet Holdings, Inc. NetIncomeLoss $14.20M USD 1 Quarter
Earnings from continuing operations IncomeLossFromContinuingOperationsPerBasicShare $1.11 USD 1 Quarter
Earnings from continuing operations IncomeLossFromContinuingOperationsPerBasicShare $0.35 USD 1 Quarter
Loss from discontinued operations IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare $-0.28 USD 1 Quarter
Net Earnings Per Common Share - Basic EarningsPerShareBasic $0.07 USD 1 Quarter
Net Earnings Per Common Share - Basic EarningsPerShareBasic $1.11 USD 1 Quarter
Earnings from continuing operations IncomeLossFromContinuingOperationsPerDilutedShare $0.35 USD 1 Quarter
Earnings from continuing operations IncomeLossFromContinuingOperationsPerDilutedShare $1.11 USD 1 Quarter
Loss from discontinued operations IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare $-0.28 USD 1 Quarter
Net Earnings Per Common Share - Diluted EarningsPerShareDiluted $0.07 USD 1 Quarter
Net Earnings Per Common Share - Diluted EarningsPerShareDiluted $1.11 USD 1 Quarter
Basic WeightedAverageNumberOfSharesOutstandingBasic 209.40M shares 1 Quarter
Basic WeightedAverageNumberOfSharesOutstandingBasic 209.20M shares 1 Quarter
Diluted WeightedAverageNumberOfDilutedSharesOutstanding 210.10M shares 1 Quarter
Diluted WeightedAverageNumberOfDilutedSharesOutstanding 210.40M shares 1 Quarter
Cash Flow Statement 68 line items
Line Item Tag Value Unit Period
Cash and cash equivalents including discontinued operations cash CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations $100.40M USD Point-in-time
Net earnings from continuing operations IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest $73.20M USD 1 Quarter
Net earnings from continuing operations IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest $232.80M USD 1 Quarter
Depreciation and amortization DepreciationDepletionAndAmortization $233.80M USD 1 Quarter
Depreciation and amortization DepreciationDepletionAndAmortization $231.80M USD 1 Quarter
Share-based compensation ShareBasedCompensation $23.20M USD 1 Quarter
Share-based compensation ShareBasedCompensation $25.00M USD 1 Quarter
(Gain) loss on investment in ZimVie GainLossOnInvestments $-51.00M USD 1 Quarter
(Gain) loss on investment in ZimVie GainLossOnInvestments $2.50M USD 1 Quarter
Income taxes IncreaseDecreaseInAccruedIncomeTaxesPayable $-2.50M USD 1 Quarter
Income taxes IncreaseDecreaseInAccruedIncomeTaxesPayable $21.50M USD 1 Quarter
Receivables IncreaseDecreaseInReceivables $14.20M USD 1 Quarter
Receivables IncreaseDecreaseInReceivables $-8.60M USD 1 Quarter
Inventories IncreaseDecreaseInInventories $600.00K USD 1 Quarter
Inventories IncreaseDecreaseInInventories $94.20M USD 1 Quarter
Accounts payable and accrued liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities $-15.90M USD 1 Quarter
Accounts payable and accrued liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities $-91.80M USD 1 Quarter
Other assets and liabilities IncreaseDecreaseInOtherOperatingCapitalNet $32.30M USD 1 Quarter
Other assets and liabilities IncreaseDecreaseInOtherOperatingCapitalNet $23.50M USD 1 Quarter
Net cash provided by operating activities from continuing operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations $307.70M USD 1 Quarter
Net cash provided by operating activities from continuing operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations $315.70M USD 1 Quarter
Additions to instruments AdditionsToInstruments $56.40M USD 1 Quarter
Additions to instruments AdditionsToInstruments $82.80M USD 1 Quarter
Additions to other property, plant and equipment PaymentsToAcquirePropertyPlantAndEquipment $36.40M USD 1 Quarter
Additions to other property, plant and equipment PaymentsToAcquirePropertyPlantAndEquipment $46.70M USD 1 Quarter
Net investment hedge settlements PaymentsForProceedsFromHedgeInvestingActivities $-12.70M USD 1 Quarter
Net investment hedge settlements PaymentsForProceedsFromHedgeInvestingActivities $-13.40M USD 1 Quarter
Business combination investments, net of acquired cash PaymentsToAcquireBusinessTwoNetOfCashAcquired $18.90M USD 1 Quarter
Other investing activities PaymentsForProceedsFromOtherInvestingActivities $1.00M USD 1 Quarter
Other investing activities PaymentsForProceedsFromOtherInvestingActivities $14.30M USD 1 Quarter
Net cash used in investing activities from continuing operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations $-149.40M USD 1 Quarter
Net cash used in investing activities from continuing operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations $-81.10M USD 1 Quarter
Proceeds from revolving facility ProceedsFromLinesOfCredit $100.00M USD 1 Quarter
Proceeds from revolving facility ProceedsFromLinesOfCredit $370.00M USD 1 Quarter
Payments on revolving facility RepaymentsOfLinesOfCredit $160.00M USD 1 Quarter
Redemption of senior notes MaturitiesOfSeniorDebt $86.30M USD 1 Quarter
Redemption of senior notes MaturitiesOfSeniorDebt $750.00M USD 1 Quarter
Payment on term loan RepaymentsOfUnsecuredDebt $33.90M USD 1 Quarter
Dividends paid to stockholders PaymentsOfDividendsCommonStock $50.20M USD 1 Quarter
Dividends paid to stockholders PaymentsOfDividendsCommonStock $50.30M USD 1 Quarter
Proceeds from employee stock compensation plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions $40.50M USD 1 Quarter
Proceeds from employee stock compensation plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions $36.00M USD 1 Quarter
Distribution from ZimVie, Inc. ProceedsFromDividendDistribution $540.60M USD 1 Quarter
Business combination contingent consideration payments PaymentForContingentConsiderationLiabilityFinancingActivities $9.60M USD 1 Quarter
Repurchase of common stock PaymentsForRepurchaseOfCommonStock $267.60M USD 1 Quarter
Other financing activities ProceedsFromPaymentsForOtherFinancingActivities $-3.30M USD 1 Quarter
Other financing activities ProceedsFromPaymentsForOtherFinancingActivities $-5.10M USD 1 Quarter
Net cash used in financing activities from continuing operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations $-206.70M USD 1 Quarter
Net cash used in financing activities from continuing operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations $-122.40M USD 1 Quarter
Net cash used in operating activities CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations - USD 1 Quarter
Net cash used in operating activities CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations $-78.50M USD 1 Quarter
Net cash used in investing activities CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations $-7.20M USD 1 Quarter
Net cash used in investing activities CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations - USD 1 Quarter
Net cash used in financing activities CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations $-68.10M USD 1 Quarter
Net cash used in financing activities CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations - USD 1 Quarter
Net cash used in discontinued operations NetCashProvidedByUsedInDiscontinuedOperations $-153.80M USD 1 Quarter
Effect of exchange rates on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $-1.10M USD 1 Quarter
Effect of exchange rates on cash and cash equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $2.90M USD 1 Quarter
Decrease in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $-42.70M USD 1 Quarter
Decrease in cash and cash equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect $-45.50M USD 1 Quarter
Cash and cash equivalents, beginning of year (includes $100.4 at January 1, 2022 of discontinued operations cash) CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $435.80M USD Point-in-time
Cash and cash equivalents, beginning of year (includes $100.4 at January 1, 2022 of discontinued operations cash) CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $375.70M USD Point-in-time
Cash and cash equivalents, beginning of year (includes $100.4 at January 1, 2022 of discontinued operations cash) CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $330.20M USD Point-in-time
Cash and cash equivalents, beginning of year (includes $100.4 at January 1, 2022 of discontinued operations cash) CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $478.50M USD Point-in-time
Cash and cash equivalents, end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $435.80M USD Point-in-time
Cash and cash equivalents, end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $375.70M USD Point-in-time
Cash and cash equivalents, end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $330.20M USD Point-in-time
Cash and cash equivalents, end of period CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $478.50M USD Point-in-time
Stockholders Equity 22 line items
Line Item Tag Value Unit Period
Cash dividend declared per share CommonStockDividendsPerShareDeclared $0.24 USD 1 Quarter
Cash dividend declared per share CommonStockDividendsPerShareDeclared $0.24 USD 1 Quarter
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.16B USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.67B USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.02B USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.03B USD Point-in-time
Net earnings ProfitLoss $232.80M USD 1 Quarter
Net earnings ProfitLoss $14.40M USD 1 Quarter
Other comprehensive income OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $1.30M USD 1 Quarter
Other comprehensive income OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $11.60M USD 1 Quarter
Cash dividends declared DividendsCommonStockCash $50.40M USD 1 Quarter
Cash dividends declared DividendsCommonStockCash $50.30M USD 1 Quarter
Reclassifications of net investment hedges OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossReclassificationBeforeTax $25.90M USD 1 Quarter
Spinoff of ZimVie Inc. StockholdersEquityNoteSpinoffTransaction $-717.90M USD 1 Quarter
Stock compensation plans StockIssuedDuringPeriodValueShareBasedCompensation $56.00M USD 1 Quarter
Stock compensation plans StockIssuedDuringPeriodValueShareBasedCompensation $71.30M USD 1 Quarter
Embody acquisition consideration StockIssuedDuringPeriodValueAcquisitions $135.00M USD 1 Quarter
Share repurchases TreasuryStockValueAcquiredCostMethod $244.00M USD 1 Quarter
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.16B USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.67B USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.02B USD Point-in-time
Balance StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest $12.03B USD Point-in-time
Comprehensive Income 14 line items
Line Item Tag Value Unit Period
Net Earnings of Zimmer Biomet Holdings, Inc. NetIncomeLoss $232.50M USD 1 Quarter
Net Earnings of Zimmer Biomet Holdings, Inc. NetIncomeLoss $14.20M USD 1 Quarter
Foreign currency cumulative translation adjustments, net of tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax $1.30M USD 1 Quarter
Foreign currency cumulative translation adjustments, net of tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax $12.40M USD 1 Quarter
Unrealized cash flow hedge gains, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax $13.70M USD 1 Quarter
Unrealized cash flow hedge gains, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax $8.80M USD 1 Quarter
Reclassification adjustments on hedges, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax $19.00M USD 1 Quarter
Reclassification adjustments on hedges, net of tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax $4.30M USD 1 Quarter
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $-900.00K USD 1 Quarter
Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax $900.00K USD 1 Quarter
Total Other Comprehensive Income OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $1.30M USD 1 Quarter
Total Other Comprehensive Income OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent $11.60M USD 1 Quarter
Comprehensive Income Attributable to Zimmer Biomet Holdings, Inc. ComprehensiveIncomeNetOfTax $25.80M USD 1 Quarter
Comprehensive Income Attributable to Zimmer Biomet Holdings, Inc. ComprehensiveIncomeNetOfTax $233.80M USD 1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.

NEWS
Loading news...
TRENDING
Loading...